These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17464751)

  • 1. Cell and gene therapy in Australia.
    Martiniello-Wilks R; Rasko JE
    Cytotherapy; 2007; 9(3):209-21. PubMed ID: 17464751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cellular therapy in Australia.
    Trickett AE; Wall DM
    Pathology; 2011 Oct; 43(6):627-34. PubMed ID: 21897330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cellular therapies: the Australian perspective.
    Wall DM; Prince HM
    Cytotherapy; 2003; 5(4):284-8. PubMed ID: 12944233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process and product development in the manufacturing of molecular therapeutics.
    Atkinson EM; Christensen JR
    Curr Opin Mol Ther; 1999 Aug; 1(4):422-9. PubMed ID: 11713755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modification of cells for transplantation.
    Lai Y; Drobinskaya I; Kolossov E; Chen C; Linn T
    Adv Drug Deliv Rev; 2008 Jan; 60(2):146-59. PubMed ID: 18037530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and stem cell therapy in peripheral arterial occlusive disease.
    Kalka C; Baumgartner I
    Vasc Med; 2008; 13(2):157-72. PubMed ID: 18593804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic solutions for degenerative disk disease.
    Fassett DR; Kurd MF; Vaccaro AR
    J Spinal Disord Tech; 2009 Jun; 22(4):297-308. PubMed ID: 19494751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products.
    Nicolette CA; Healey D; Tcherepanova I; Whelton P; Monesmith T; Coombs L; Finke LH; Whiteside T; Miesowicz F
    Vaccine; 2007 Sep; 25 Suppl 2():B47-60. PubMed ID: 17669561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in esophageal cancer gene therapy.
    Shimada H; Matsushita K; Tagawa M
    Ann Thorac Cardiovasc Surg; 2008 Feb; 14(1):3-8. PubMed ID: 18292732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in traumatic brain injury.
    Jain KK
    Drug Discov Today; 2008 Dec; 13(23-24):1082-9. PubMed ID: 18848641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous cardiac stem cells.
    Barile L; Messina E; Giacomello A; Marbán E
    Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of regulations on translational research in cell and gene therapy: the American experience].
    Rousseau RF; Gee AP
    Bull Cancer; 2004 Mar; 91(3):239-47. PubMed ID: 15171048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration.
    Asahara T
    Handb Exp Pharmacol; 2007; (180):181-94. PubMed ID: 17554509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU; de Vellis J
    J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA-based gene transfer as a tool for gene and cell therapy.
    Van Tendeloo VF; Ponsaerts P; Berneman ZN
    Curr Opin Mol Ther; 2007 Oct; 9(5):423-31. PubMed ID: 17932806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.